RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?
2013-01-01 Staropoli, Nicoletta; Ciliberto, Domenico; Botta, Cirino; Fiorillo, Lucia; Gualtieri, Simona; Salvino, Angela; Tagliaferri, P; Tassone, P
A SCID-hu in vivo model of human Waldenstrom macroglobulinemia
2005-01-01 Tassone, P; Neri, P; Kutok, Jl; Tournilhac, O; Santos, Dd; Hatjiharissi, E; Munshi, V; Venuta, S; Anderson, Kc; Treon, Sp; Munshi, Nc
A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate?
2015-01-01 Ciliberto, D; Staropoli, N; Caglioti, F; Gualtieri, S; Fiorillo, L; Chiellino, S; De Angelis, Am; Mendicino, F; Botta, C; Caraglia, M; Tagliaferri, P; Tassone, P
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells
2011-01-01 Calimeri, T; Battista, E; Conforti, F; Neri, P; Di Martino, Mt; Foresta, U; Piro, E; Ferrara, F; Bahlis, N; Anderson, Kc; Munshi, N; Causa, F; Tassone, P; Tagliaferri, P; Amorosi, A; Rossi, M
Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43
2014-01-01 Tuccillo, Fm; de Laurentiis, A; Palmieri, C; Fiume, G; Bonelli, P; Borrelli, A; Tassone, P; Scala, I; Buonaguro, Fm; Quinto, I; Scala, G
Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase(TDAC) inhibitor LBH589 are synergistic in myeloma cells
2006-01-01 Catley, L; Weisberg, E; Kiziltepe, T; Tai, Yt; Hideshima, T; Neri, P; Tassone, P; Atadja, P; Chauhan, D; Munshi, Nc; Anderson, Kc
Alkyl phospholipid perifosine induces myeloid hyperplasia in a murine myeloma model
2007-01-01 Catley, L; Hideshima, T; Chauhan, D; Neri, P; Tassone, P; Bronson, R; Song, W; Tai, Yt; Munshi, Nc; Anderson, Kc
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221
2020-01-01 Di Martino, M. T.; Arbitrio, M.; Fonsi, M.; Erratico, C. A.; Scionti, F.; Caracciolo, D.; Tagliaferri, P.; Tassone, P.
Alternative non-homologous end-joining: Error-prone dna repair as cancer’s achilles’ heel
2021-01-01 Caracciolo, D.; Riillo, C.; Di Martino, M. T.; Tagliaferri, P.; Tassone, P.
Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF-kB/Rel trascription factors
1999-01-01 Romano, Mf; Lamberti, A; Bisogni, R; Garbi, C; Pagnano, Am; Auletta, P; Tassone, P; Turco, Mc; Venuta, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it? | 1-gen-2013 | Staropoli, Nicoletta; Ciliberto, Domenico; Botta, Cirino; Fiorillo, Lucia; Gualtieri, Simona; Salvino, Angela; Tagliaferri, P; Tassone, P | |
| A SCID-hu in vivo model of human Waldenstrom macroglobulinemia | 1-gen-2005 | Tassone, P; Neri, P; Kutok, Jl; Tournilhac, O; Santos, Dd; Hatjiharissi, E; Munshi, V; Venuta, S; Anderson, Kc; Treon, Sp; Munshi, Nc | |
| A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate? | 1-gen-2015 | Ciliberto, D; Staropoli, N; Caglioti, F; Gualtieri, S; Fiorillo, L; Chiellino, S; De Angelis, Am; Mendicino, F; Botta, C; Caraglia, M; Tagliaferri, P; Tassone, P | |
| A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells | 1-gen-2011 | Calimeri, T; Battista, E; Conforti, F; Neri, P; Di Martino, Mt; Foresta, U; Piro, E; Ferrara, F; Bahlis, N; Anderson, Kc; Munshi, N; Causa, F; Tassone, P; Tagliaferri, P; Amorosi, A; Rossi, M | |
| Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43 | 1-gen-2014 | Tuccillo, Fm; de Laurentiis, A; Palmieri, C; Fiume, G; Bonelli, P; Borrelli, A; Tassone, P; Scala, I; Buonaguro, Fm; Quinto, I; Scala, G | |
| Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase(TDAC) inhibitor LBH589 are synergistic in myeloma cells | 1-gen-2006 | Catley, L; Weisberg, E; Kiziltepe, T; Tai, Yt; Hideshima, T; Neri, P; Tassone, P; Atadja, P; Chauhan, D; Munshi, Nc; Anderson, Kc | |
| Alkyl phospholipid perifosine induces myeloid hyperplasia in a murine myeloma model | 1-gen-2007 | Catley, L; Hideshima, T; Chauhan, D; Neri, P; Tassone, P; Bronson, R; Song, W; Tai, Yt; Munshi, Nc; Anderson, Kc | |
| Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 | 1-gen-2020 | Di Martino, M. T.; Arbitrio, M.; Fonsi, M.; Erratico, C. A.; Scionti, F.; Caracciolo, D.; Tagliaferri, P.; Tassone, P. | |
| Alternative non-homologous end-joining: Error-prone dna repair as cancer’s achilles’ heel | 1-gen-2021 | Caracciolo, D.; Riillo, C.; Di Martino, M. T.; Tagliaferri, P.; Tassone, P. | |
| Amifostine inhibits hematopoietic progenitor cell apoptosis by activating NF-kB/Rel trascription factors | 1-gen-1999 | Romano, Mf; Lamberti, A; Bisogni, R; Garbi, C; Pagnano, Am; Auletta, P; Tassone, P; Turco, Mc; Venuta, S |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 314
- 1 Contributo su Rivista::1.1 Arti... 314
Data di pubblicazione
- 2020 - 2023 49
- 2010 - 2019 159
- 2000 - 2009 86
- 1990 - 1999 18
- 1982 - 1989 2
Editore
- PERGAMON-ELSEVIER SCIENCE LTD, TH... 1
Rivista
- BLOOD 23
- ONCOTARGET 18
- LEUKEMIA 17
- CLINICAL CANCER RESEARCH 16
- CANCERS 11
- CANCER BIOLOGY & THERAPY 10
- CURRENT CANCER DRUG TARGETS 7
- MOLECULAR THERAPY NUCLEIC ACIDS 6
- BRITISH JOURNAL OF CANCER 5
- BRITISH JOURNAL OF HAEMATOLOGY 5
Keyword
- multiple myeloma 13
- Humans 9
- Multiple myeloma 8
- microRNA 7
- Multiple Myeloma 7
- immunotherapy 6
- cancer 5
- miRNA 5
- Apoptosis 4
- Cancer 4
Lingua
- eng 262
- ita 2
Accesso al fulltext
- no fulltext 314